XML 52 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Goodwill and Intangible Assets
3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets  
Goodwill and Intangible Assets

9.    Goodwill and Intangible Assets

The following table sets forth the changes in the carrying amount of goodwill for the three months ended March 31, 2020 (dollars in millions):

BSI Life

Science

BSI NANO

BEST

Total

Balance at December 31, 2019

    

$

84.2

$

208.5

$

0.3

$

293.0

Foreign currency impact

(0.3)

(2.7)

(3.0)

Balance at March 31, 2020

$

83.9

$

205.8

$

0.3

$

290.0

The following is a summary of intangible assets, excluding goodwill (dollars in millions):

March 31, 2020

December 31, 2019

Gross

Gross

Carrying

Accumulated

Net Carrying

Carrying

Accumulated

Net Carrying

    

Amount

    

Amortization

    

Amount

    

Amount

    

Amortization

    

Amount

Existing technology and related patents

$

298.4

$

(186.7)

$

111.7

$

300.9

$

(182.4)

$

118.5

Customer relationships

 

132.9

 

(33.8)

 

99.1

 

134.7

 

(30.9)

 

103.8

Non compete contracts

 

1.8

 

(1.8)

 

1.8

(1.8)

Trade names

 

13.5

 

(3.2)

 

10.3

 

13.7

 

(2.9)

 

10.8

Other

5.5

(5.4)

0.1

5.5

(5.4)

0.1

Intangible assets

$

452.1

$

(230.9)

$

221.2

$

456.6

$

(223.4)

$

233.2

For the three months ended March 31, 2020 and 2019, the Company recorded amortization expense of $8.7 million and $10.1 million, respectively, related to intangible assets subject to amortization.

During the three months ended March 31, 2020, as a result of the impact of the COVID-19 pandemic, the Company performed an interim impairment assessment of the goodwill balance as of March 31, 2020 using a combination of both quantitative and qualitative approaches. Based on this interim assessment, the Company concluded the fair values of each of the reporting units were significantly greater than their carrying amounts, and therefore, no impairment is required. The goodwill assessments were based on management's estimates and assumptions, a number of which are dependent on external factors. To the extent actual results differ materially from these estimates and the Company experiences further negative developments in subsequent periods, interim impairment assessments could be required, which could result in an impairment of goodwill.